Details of the Drug Reposition

General Information of This Drug (ID: DMZ763A)

• Drug Name: Autologous T Cells Expressing MET scFv CAR (DMZ763A)
• Drug Type: CAR T Cell Therapy

Information on Drug Reposition of This Drug

1 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Melanoma	DIS1RRCY	2C30	Phase 1	[1]

1 Phase 0 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Breast cancer	DIS7DPX1	2C60-2C65	Phase 0	[1]

References

• [1] ClinicalTrials.gov (NCT03060356) Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)